Renaissance Technologies’s TScan Therapeutics TCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.15M | Buy |
792,056
+622,350
| +367% | +$902K | ﹤0.01% | 2434 |
|
2025
Q1 | $234K | Buy |
169,706
+159,106
| +1,501% | +$220K | ﹤0.01% | 3027 |
|
2024
Q4 | $32.2K | Sell |
10,600
-63,400
| -86% | -$193K | ﹤0.01% | 3444 |
|
2024
Q3 | $369K | Sell |
74,000
-6,000
| -8% | -$29.9K | ﹤0.01% | 2902 |
|
2024
Q2 | $468K | Buy |
80,000
+33,000
| +70% | +$193K | ﹤0.01% | 2718 |
|
2024
Q1 | $373K | Buy |
47,000
+25,300
| +117% | +$201K | ﹤0.01% | 2993 |
|
2023
Q4 | $127K | Buy |
21,700
+4,000
| +23% | +$23.4K | ﹤0.01% | 3243 |
|
2023
Q3 | $45K | Sell |
17,700
-129,762
| -88% | -$330K | ﹤0.01% | 3421 |
|
2023
Q2 | $369K | Buy |
147,462
+135,862
| +1,171% | +$340K | ﹤0.01% | 3032 |
|
2023
Q1 | $24K | Buy |
11,600
+1,600
| +16% | +$3.31K | ﹤0.01% | 3796 |
|
2022
Q4 | $16K | Buy |
+10,000
| New | +$16K | ﹤0.01% | 3996 |
|
2022
Q2 | – | Sell |
-13,300
| Closed | -$37K | – | 4567 |
|
2022
Q1 | $37K | Buy |
+13,300
| New | +$37K | ﹤0.01% | 3948 |
|